COL11A1 and non-small cell lung carcinoma: Therefore, we analyzed whether ITGA11 and COL11A1 regulate CAF‐mediated bioactivity through fibronectin or collagen type I and could potentially serve as highly specific biomarkers for activated CAFs in NSCLC patients.